Search

FDA Approved Drug for Hepatitis C: New Fixed-Dose Combination - Sofosbuvir, Velpatasvir and Voxilaprevir

FDA APPROVED DRUG FOR HEPATITIS C: NEW FIXED-DOSE COMBINATION - SOFOSBUVIR, VELPATASVIR AND VOXILAPREVIR

The US FDA has approved a fixed-dose combination of sofosbuvir, velpatasvir and voxilaprevir for the treatment of hepatitis C.